Phase 1 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with ovarian, testicular, or endometrial cancer that tests positive for a protein called CLDN6, and whose cancer has stopped responding to platinum-based chemotherapy or has come back after treatment.
- People whose cancer can be measured on scans according to a standard set of measurement rules called RECIST 1.1.
- People who are reasonably active and able to carry out daily activities (rated on a standard scale as 0, 1, or 2), and whose doctors expect them to live for at least 12 weeks.
- People whose liver, kidneys, heart, and other organs are functioning well enough to take part in the trial.
Who may not be able to join:
- People whose cancer has spread to the brain, the lining of the brain or spinal cord, or is pressing on the spinal cord.
- People with a serious active infection that is not under control, or any other medical condition that the trial doctor believes would make it unsafe to take part.
- People who are already taking part in another clinical trial that is testing an investigational treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karen Chagin, MD, Context Therapeutics Inc.
Phone: 267-225-7416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Dose Limiting Toxicities (DLTs); Overall response rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.